Terms: = Sarcomas AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1
64 results:
1. Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome.
Trujillo-Paolillo A; Tesser-Gamba F; Seixas Alves MT; Filho RJG; Oliveira R; Petrilli AS; Toledo SRC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982681
[TBL] [Abstract] [Full Text] [Related]
2. Stathmin expression alters the antiproliferative effect of eribulin in leiomyosarcoma cells.
Azumi M; Yoshie M; Nakachi N; Tsuru A; Kusama K; Tamura K
J Pharmacol Sci; 2022 Dec; 150(4):259-266. PubMed ID: 36344048
[TBL] [Abstract] [Full Text] [Related]
3. Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages.
Wang J; Jin J; Chen T; Zhou Q
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889217
[TBL] [Abstract] [Full Text] [Related]
4. Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer.
Mateu-Sanz M; Ginebra MP; Tornín J; Canal C
Free Radic Biol Med; 2022 Aug; 189():32-41. PubMed ID: 35843475
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells.
Moiseeva NI; Laletina LA; Fetisov TI; Makhmudova LF; Manikaylo AE; Fomina LY; Burov DA; Lesovaya EA; Bokhyan BY; Zinovieva VY; Vilkova AS; Mekheda LV; Kozlov NA; Scherbakov AM; Kirilin EM; Belitsky GA; Yakubovskaya MG; Kirsanov KI
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328603
[TBL] [Abstract] [Full Text] [Related]
6. Surface osteosarcoma: Predictors of outcomes.
Lee SJ; Lans J; Cook SD; Chebib I; Schwab JH; Raskin KA; Lozano-Calderón S
J Surg Oncol; 2021 Sep; 124(4):646-654. PubMed ID: 34043244
[TBL] [Abstract] [Full Text] [Related]
7. Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.
Kawachi H; Kunimasa K; Kukita Y; Nakamura H; Honma K; Kawamura T; Inoue T; Tamiya M; Kuhara H; Nishino K; Mizote Y; Akazawa T; Tahara H; Kumagai T
Immunotherapy; 2021 Jul; 13(10):799-806. PubMed ID: 34030451
[TBL] [Abstract] [Full Text] [Related]
8. SMAR1 attenuates the stemness of osteosarcoma cells via through suppressing abcg2 transcriptional activity.
Xu H; Liu T; Li W; Yao Q
Environ Toxicol; 2021 Jun; 36(6):1090-1098. PubMed ID: 33543840
[TBL] [Abstract] [Full Text] [Related]
9. High expression of abcg2 is associated with chemotherapy resistance of osteosarcoma.
Shu H; Yuan B; Huang Y; Wang L; He B; Sun Q; Sun L
J Orthop Surg Res; 2021 Jan; 16(1):85. PubMed ID: 33509236
[TBL] [Abstract] [Full Text] [Related]
10. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM
Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252
[TBL] [Abstract] [Full Text] [Related]
11. Poncirin downregulates ATP-binding cassette transporters to enhance cisplatin sensitivity in cisplatin-resistant osteosarcoma cells.
Zhao L; Zhang W; Zhang F
Phytother Res; 2021 Jan; 35(1):278-288. PubMed ID: 32779800
[TBL] [Abstract] [Full Text] [Related]
12. Suppressing STAT5 signaling affects osteosarcoma growth and stemness.
Subramaniam D; Angulo P; Ponnurangam S; Dandawate P; Ramamoorthy P; Srinivasan P; Iwakuma T; Weir SJ; Chastain K; Anant S
Cell Death Dis; 2020 Feb; 11(2):149. PubMed ID: 32094348
[TBL] [Abstract] [Full Text] [Related]
13. ALK
Xu BS; Chen HY; Que Y; Xiao W; Zeng MS; Zhang X
Oncogene; 2020 Jan; 39(1):151-163. PubMed ID: 31462708
[TBL] [Abstract] [Full Text] [Related]
14. Chemo-sensitizing activity of natural cadinanes from Heterotheca inuloides in human uterine sarcoma cells and their in silico interaction with ABC transporters.
Rodríguez-Chávez JL; Méndez-Cuesta CA; Ramírez-Apan T; Egas V; Ávila JL; Neira-González A; Hernández T; Espinosa-García FJ; Delgado G
Bioorg Chem; 2019 Oct; 91():103091. PubMed ID: 31319298
[TBL] [Abstract] [Full Text] [Related]
15. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and bcrp transporters to overcome multidrug resistance in cancer cells.
Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
[TBL] [Abstract] [Full Text] [Related]
16. CCN2 promotes drug resistance in osteosarcoma by enhancing abcg2 expression.
Tsai HC; Chang AC; Tsai CH; Huang YL; Gan L; Chen CK; Liu SC; Huang TY; Fong YC; Tang CH
J Cell Physiol; 2019 Jun; 234(6):9297-9307. PubMed ID: 30317661
[TBL] [Abstract] [Full Text] [Related]
17. Uncoupling Warburg effect and stemness in CD133
Koka P; Mundre RS; Rangarajan R; Chandramohan Y; Subramanian RK; Dhanasekaran A
Mol Biol Rep; 2018 Dec; 45(6):1653-1662. PubMed ID: 30128626
[TBL] [Abstract] [Full Text] [Related]
18. Correlation of IGF1R expression with abcg2 and CD44 expressions in human osteosarcoma.
Kim CK; Oh S; Kim SJ; Leem SH; Heo J; Chung SH
Genes Genomics; 2018 Apr; 40(4):381-388. PubMed ID: 29892839
[TBL] [Abstract] [Full Text] [Related]
19. A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial.
Lui G; Treluyer JM; Fresneau B; Piperno-Neumann S; Gaspar N; Corradini N; Gentet JC; Marec Berard P; Laurence V; Schneider P; Entz-Werle N; Pacquement H; Millot F; Taque S; Freycon C; Lervat C; Le Deley MC; Mahier Ait Oukhatar C; Brugieres L; Le Teuff G; Bouazza N;
J Clin Pharmacol; 2018 Dec; 58(12):1541-1549. PubMed ID: 29791011
[TBL] [Abstract] [Full Text] [Related]
20. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.
Li PC; Tu MJ; Ho PY; Jilek JL; Duan Z; Zhang QY; Yu AX; Yu AM
Drug Metab Dispos; 2018 Jan; 46(1):2-10. PubMed ID: 29061583
[TBL] [Abstract] [Full Text] [Related]
[Next]
